GenieUs Genomics Announces Completion of Phase 2 Clinical Trial Enrollment
A Key Step Forward in Addressing the Heterogeneity of ALS to Unlock Precision Treatments SYDNEY, NSW, AUSTRALIA, October 2, 2024 /EINPresswire.com/ -- GenieUs Genomics (GenieUs), in collaboration with trial sites at Duke University School of …